Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company was founded in 2008 and is headquartered in Irving, Texas. Show more
Location: 750 West John Carpenter Freeway, Irving, TX, 75039, United States | Website: https://www.carislifesciences.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
10.4B
52 Wk Range
$25.40 - $39.80
Previous Close
$34.28
Open
$34.00
Volume
1,106,564
Day Range
$33.34 - $37.62
Enterprise Value
10.1B
Cash
721.2M
Avg Qtr Burn
-33.1M
Insider Ownership
49.10%
Institutional Own.
25.14%
Qtr Updated
06/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|